Med-Chemist : "Quintessential Medicinal Chemistry"
Saturday, February 13, 2010
Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases
Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment